Search results

This report represents one of many steps needed to help understand the factors that shape race inequality in health, including the forces of structural racism and discrimination, and to begin to respond to them with impactful changes. Knowing how the system works, and how it interacts with underserved communities, is an important step towards rebuilding that system in a way that truly has equality at its core. We invite those reading this report to join us on that journey.

This report draws on a longer study we commissioned from The King’s Fund (Chauhan et al 2021).

This report sets out to understand the broad availability of digital products and services that currently exist. The report explores the range of technology that is in place for Accident and Emergency clinicians, red-cell specialists, and ambulance care, to aid timely support to sufferers on their emergency hospital arrival.

One of the best things about my role is speaking to staff. Since becoming Interim Chair, I’ve tried to meet as many staff as possible. Not only is it a critical part of the role, but it’s also one of the parts of the job I enjoy most. And so, while talking to a member of staff from Birmingham and Solihull ICS, they took the opportunity to ask me ‘‘What does Windrush mean for the NHS?

“Health and care organisations must become better aligned in their duty of care to improve healthcare services for black and minority ethnic patients resulting in substantial shifts towards more positive outcomes for diverse communities.

In April 2021, the NHS Race and Health Observatory published a rapid review with recommendations into the accuracy of Pulse Oximeter readings for people from black, Asian and minority ethnic backgrounds.

Barriers to treatment, support and emergency healthcare faced by patients experiencing acute painful sickle cell episodes will be investigated by the NHS Race and Health Observatory.

People with a learning disability from Black, South Asian (Indian, Pakistani or Bangladeshi heritage) and minority ethnic backgrounds face shorter life expectancy triggered by poorer healthcare access, experience and outcomes.

A new pilot project aimed at increasing the number of Black, Asian and ethnic minority patients taking part in potentially life-enhancing breast cancer clinical trials has been announced today, 31 August.

First Do No Harm, the independent review of the safety of medicines and medical devices led by Baroness Julia Cumberlege, found that patients’ voices were ignored, and that the health system did not listen and act, but was defensive, dismissive, and disjointed. As the first ever Patient Safety Commissioner I have been listening to patients and patient safety experts to understand what needs to improve.